Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             65 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A case of anti-MOG antibody-positive unilaterally dominant meningoencephalitis followed by longitudinally extensive transverse myelitis Sugimoto, Takamichi
2018
25 C p. 128-130
artikel
2 A contemporary study of mortality in the multiple sclerosis population of south east Wales Harding, Katharine
2018
25 C p. 186-191
artikel
3 Adult-onset hemophagocytic lymphohistiocytosis type 2 presenting as a demyelinating disease Algahtani, Hussein
2018
25 C p. 77-82
artikel
4 Alemtuzumab-containing reduced intensity conditioning allogenic hematopoietic stem cell transplantation in a case of primary progressive multiple sclerosis AlKhaja, Mohamed
2018
25 C p. 334-336
artikel
5 An interesting PRESentation of NMO Klenofsky, B
2018
25 C p. 163-164
artikel
6 An MRI evaluation of grey matter damage in African Americans with MS Petracca, Maria
2018
25 C p. 29-36
artikel
7 Association between brain atrophy and cognitive motor interference in multiple sclerosis Coghe, Giancarlo
2018
25 C p. 208-211
artikel
8 A systematic critical review of physical activity aspects in clinical guidelines for multiple sclerosis Geidl, Wolfgang
2018
25 C p. 200-207
artikel
9 Azathioprine-induced pellagra in neuromyelitis optica: A case report and review of literature Zhao, Cong
2018
25 C p. 104-107
artikel
10 Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis Bensi, C
2018
25 C p. 246-250
artikel
11 Cardiovascular conditions in persons with multiple sclerosis, neuromyelitis optica and transverse myelitis Saroufim, Paola
2018
25 C p. 21-25
artikel
12 CLIPPERS syndrome responsive to Leflunomide: A case report Didier, Parada-Garza Juan
2018
25 C p. 265-267
artikel
13 Co-ocurrence of neurosarcoidosis and intrathecal reactivation of Epstein-Barr virus Salazar, Richard
2018
25 C p. 297-299
artikel
14 Coping strategies and quality of life in Mexican multiple sclerosis patients: Physical, psychological and social factors relationship Hernández-Ledesma, Ana Laura
2018
25 C p. 122-127
artikel
15 Decreasing longitudinal use of glucocorticosteroids in multiple sclerosis Ellenberger, David
2018
25 C p. 173-174
artikel
16 Development and validation of a multidimensional health literacy questionnaire for multiple sclerosis patients Dehghani, Ali
2018
25 C p. 156-162
artikel
17 Dysregulation of long non-coding RNA profile in peripheral blood of multiple sclerosis patients Dastmalchi, Romina
2018
25 C p. 219-226
artikel
18 Effects of cigarette smoking on respiratory problems and functional levels in multiple sclerosis patients Aktan, Ridvan
2018
25 C p. 271-275
artikel
19 Efficacy and safety of monoclonal antibody therapies for relapsing remitting multiple sclerosis: A network meta-analysis Xu, Xinghua
2018
25 C p. 322-328
artikel
20 Epstein Barr virus shedding in multiple sclerosis: Similar frequencies of EBV in saliva across separate patient cohorts Holden, David W
2018
25 C p. 197-199
artikel
21 Establishing the diagnosis of multiple sclerosis in Croatian patients with clinically isolated syndrome: 2010 versus 2017 McDonald criteria Habek, Mario
2018
25 C p. 99-103
artikel
22 Evidence of attentional impairments using virtual driving simulation in multiple sclerosis Harand, C.
2018
25 C p. 251-257
artikel
23 Factors associated with perceived need for mental health care in multiple sclerosis Orr, Justine
2018
25 C p. 179-185
artikel
24 Fake news, influencers and health-related professional participation on the Web: A pilot study on a social-network of people with Multiple Sclerosis Lavorgna, L.
2018
25 C p. 175-178
artikel
25 Flaccid paralysis in neuromyelitis optica: An atypical presentation with possible involvement of the peripheral nervous system Grüter, Thomas
2018
25 C p. 83-86
artikel
26 Gynecological adverse effects of natalizumab administration: Case report and review of the literature Makris, Georgios-Marios
2018
25 C p. 46-49
artikel
27 Identifying optic neuritis and transverse myelitis using administrative data Marrie, Ruth Ann
2018
25 C p. 258-264
artikel
28 Increased CCL18 plasma levels are associated with neurodegenerative MRI outcomes in multiple sclerosis patients Ziliotto, Nicole
2018
25 C p. 37-42
artikel
29 Influences of pregnancy on neuromyelitis optica spectrum disorders and multiple sclerosis Tong, Yanping
2018
25 C p. 61-65
artikel
30 Intrathecal K free light chain synthesis in multiple sclerosis at clinical onset associates with local IgG production and improves the diagnostic value of cerebrospinal fluid examination Puthenparampil, M.
2018
25 C p. 241-245
artikel
31 Is there an effect of dietary intake on MS-related fatigue? – A systematic literature review Pommerich, Uwe Martin
2018
25 C p. 282-291
artikel
32 Key considerations in reimbursement decision-making for multiple sclerosis drugs in Australia Phan, Yen Hoang Le
2018
25 C p. 144-149
artikel
33 Lower extremity deep venous thrombosis in a multiple sclerosis patient on dimethyl fumarate Mirmosayyeb, Omid
2018
25 C p. 196
artikel
34 Lower frequency of antibodies to MOG in Brazilian patients with demyelinating diseases: An ethnicity influence? Papais-Alvarenga, Regina Maria
2018
25 C p. 87-94
artikel
35 Low vitamin D-25(OH) level in Indonesian multiple sclerosis and neuromyelitis optic patients Kusumadewi, Winda
2018
25 C p. 329-333
artikel
36 Measures of adiposity differentially correlate with C-reactive protein among persons with multiple sclerosis Baynard, Tracy
2018
25 C p. 1-4
artikel
37 Metabolomic profile of insulin resistance in patients with multiple sclerosis is associated to the severity of the disease Ruiz-Argüelles, Alejandro
2018
25 C p. 316-321
artikel
38 Mining healthcare data for markers of the multiple sclerosis prodrome Högg, Tanja
2018
25 C p. 232-240
artikel
39 MOG antibody disease: A review of MOG antibody seropositive neuromyelitis optica spectrum disorder Narayan, Ram
2018
25 C p. 66-72
artikel
40 Multiple sclerosis and neuromyelitis optica spectrum disorders in Malaysia: A comparison in different ethnic groups Viswanathan, S
2018
25 C p. 300-308
artikel
41 Multiple sclerosis prevalence in Salta City, Argentina Mellinger, S.
2018
25 C p. 212-215
artikel
42 Myocardial infarction in a patient with multiple sclerosis after receiving natalizumab Darki, Aala
2018
25 C p. 26-28
artikel
43 Neuromyelitis optica spectrum disorder and multiple sclerosis in a Sardinian family Gelibter, S
2018
25 C p. 73-76
artikel
44 No association between socioeconomic status and risk of multiple sclerosis: A population-based incident case-control study in a developing country Abdollahpour, Ibrahim
2018
25 C p. 292-296
artikel
45 No C9orf72 repeat expansion in patients with primary progressive multiple sclerosis Tiloca, Cinzia
2018
25 C p. 192-195
artikel
46 Obstetric outcomes in a Mexican cohort of patients with AQP4-antibody-seropositive neuromyelitis optica Delgado-García, Guillermo
2018
25 C p. 268-270
artikel
47 Oligoclonal bands in multiple sclerosis; Functional significance and therapeutic implications. Does the specificity matter? Pryce, Gareth
2018
25 C p. 131-137
artikel
48 Outcomes and treatment management of a French cohort suffering from multiple sclerosis: A retrospective epidemiological study Defer, G.
2018
25 C p. 276-281
artikel
49 Pediatric-onset multiple sclerosis in Brazilian patients: Clinical features, treatment response and comparison to pediatric neuromyelitis optica spectrum disorders Fragomeni, Manuela de Oliveira
2018
25 C p. 138-142
artikel
50 Perceived cognitive deficits and depressive symptoms in patients with multiple sclerosis: Perceived stress and sleep quality as mediators Lamis, Dorian A.
2018
25 C p. 150-155
artikel
51 Protective effects of hydro-ethanolic extract of Terminalia chebula on primary microglia cells and their polarization (M1/M2 balance) Rahimi, Vafa Baradaran
2018
25 C p. 5-13
artikel
52 Refactory Trigeminal Neuralgia successfully treated by combination therapy (Pregabalin plus Lamotrigine) Solaro, Claudio Marcello
2018
25 C p. 165-166
artikel
53 Refining the Nosology of Antigen-Specific Diseases Within the Spectrum of Neuromyelitis Optica Levy, Michael
2018
25 C p. A1-A2
artikel
54 Resilience and depression/anxiety symptoms in multiple sclerosis and neuromyelitis optica spectrum disorder Nakazawa, Kanako
2018
25 C p. 309-315
artikel
55 Shortening the washout to 4 weeks when switching from natalizumab to fingolimod and risk of disease reactivation in multiple sclerosis Naegelin, Y.
2018
25 C p. 14-20
artikel
56 The disease burden of Multiple Sclerosis from the individual and population perspective: Which symptoms matter most? Barin, Laura
2018
25 C p. 112-121
artikel
57 The frequency of dysphagia and its impact on adults with multiple sclerosis based on patient-reported questionnaires Alali, Dalal
2018
25 C p. 227-231
artikel
58 The prevalence, incidence and familial recurrence of multiple sclerosis in Tehran, Iran Eskandarieh, Sharareh
2018
25 C p. 143
artikel
59 The relationship between depression, anxiety and cognition and its paradoxical impact on falls in multiple sclerosis patients Kalron, Alon
2018
25 C p. 167-172
artikel
60 Toxic liver injury after high-dose methylprednisolone in people with multiple sclerosis Adamec, Ivan
2018
25 C p. 43-45
artikel
61 Treatment retention on fingolimod compared with injectable multiple sclerosis therapies in African-American patients: A subgroup analysis of a randomized phase 4 study Cascione, Mark
2018
25 C p. 50-56
artikel
62 Tumefactive multiple sclerosis lesions associated with fingolimod treatment: Report of 5 cases Sánchez, Pedro
2018
25 C p. 95-98
artikel
63 Unexpected high multiple sclerosis activity after switching from fingolimod to alemtuzumab Bernard-Valnet, Raphaël
2018
25 C p. 216-218
artikel
64 Use of the new oral disease-modifying therapies for multiple sclerosis in British Columbia, Canada: the first five-years Setayeshgar, Solmaz
2018
25 C p. 57-60
artikel
65 User testing as a method for evaluating subjects’ understanding of informed consent in clinical trials in multiple sclerosis Ponzio, Michela
2018
25 C p. 108-111
artikel
                             65 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland